Proteins of the innate immune system known as the alternative pathway of complement have recently been linked to approximately 74% of the cases of age-related macular degeneration (ARMD). Several years ago it was genetically linked to inherited hemolytic uremic syndrome (aHUS). Both of these diseases are associated with mutations in the complement protein factor H. Factor H is the primary regulator of alternative pathway activation. A common allele of factor B has been shown to be protective for ARMD. Factor B is central to activation of the alternative pathway and its activation is controlled by factor H. ARMD is the leading cause of blindness in the developed countries and 30% of people over the age of 65 have ARMD or show early signs of the disease. Much progress toward understanding the functions of factor H and factor B has been made in the previous grant. We have determined the NMR-derived 3D structure of the two domains in factor H involved in aHUS and characterized the function of these domains. Extensive studies of the C5-activating enzyme formed by factor B have also been completed. The present grant proposes to continue this work now focusing on ARMD-related structures and their functional consequences in complement activation. Activation of the alternative pathway is capable of inflicting great damage to host tissues and has been associated with many diseases. The proposed research will investigate disease-associated alleles in factor H and identify and characterize what now appear to be tissue specific recognition sites in the 20 domains of factor H. Novel approaches have recently been developed in our lab to characterize the tissue-specific receptors for these sites and to examine the functional role of each site. Several of these sites have already been shown to be critical for regulation of complement activation on host cells and tissues. Alleles of factor B will also be examined and their functional consequences evaluated to understand the mechanism by which these alterations provide protection from macular degeneration. Relevance: The benefits of this research will be a better understanding of the molecular pathology of inherited hemolytic uremic syndrome and of age-related macular degeneration (ARMD). Recent discoveries point to the alternative pathway of complement as a major contributor to these diseases. This proposal will examine the molecular events leading to tissue damage in these and other diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK035081-25
Application #
7773509
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Wright, Daniel G
Project Start
1984-09-01
Project End
2012-02-29
Budget Start
2010-03-01
Budget End
2011-02-28
Support Year
25
Fiscal Year
2010
Total Cost
$246,126
Indirect Cost
Name
University of Texas Health Center at Tyler
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
800772337
City
Tyler
State
TX
Country
United States
Zip Code
75708
Ferreira, Viviana P; Fazito Vale, Vladimir; Pangburn, Michael K et al. (2016) SALO, a novel classical pathway complement inhibitor from saliva of the sand fly Lutzomyia longipalpis. Sci Rep 6:19300
Singh, Sanjay K; Thirumalai, Avinash; Hammond Jr, David J et al. (2012) Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis. J Biol Chem 287:3550-8
Hadders, Michael A; Bubeck, Doryen; Roversi, Pietro et al. (2012) Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep 1:200-7
Takeda, Katsuyuki; Thurman, Joshua M; Tomlinson, Stephen et al. (2012) The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation. J Immunol 188:661-7
Cortes, Claudio; Ferreira, V P; Pangburn, Michael K (2011) Native properdin binds to Chlamydia pneumoniae and promotes complement activation. Infect Immun 79:724-31
Renner, Brandon; Ferreira, Viviana P; Cortes, Claudio et al. (2011) Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury. Kidney Int 80:165-73
Ferreira, Viviana P; Pangburn, Michael K; Cortes, Claudio (2010) Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 47:2187-97
Renner, Brandon; Coleman, Kathrin; Goldberg, Ryan et al. (2010) The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells. J Immunol 185:3086-94
Rohrer, Bärbel; Long, Qin; Coughlin, Beth et al. (2010) A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv Exp Med Biol 703:137-49
Agarwal, Sarika; Ferreira, Viviana P; Cortes, Claudio et al. (2010) An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol 185:507-16

Showing the most recent 10 out of 58 publications